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Abstract
Most population-based estimates of incident hospitalized heart failure (HF) have not differentiated
acute decompensated heart failure (ADHF) from chronic stable HF nor included racially diverse
populations. The Atherosclerosis Risk in Communities Study conducted surveillance of
hospitalized HF events (age ≥55 years) in 4 US communities. We estimated hospitalized ADHF
incidence and survival by race and gender. Potential 2005 to 2009 HF hospitalizations were
identified by International Classification of Diseases, Ninth Revision, Clinical Modification,
codes; 6,168 records were reviewed to validate ADHF cases. Population estimates were derived
from US Census data; 50% of eligible hospitalizations were classified as ADHF, of which 63.6%
were incident ADHF and 36.4% were recurrent ADHF. The average incidence of hospitalized
ADHF was 11.6 per 1,000 persons, aged ≥55 years, per year, and recurrent hospitalized ADHF
was 6.6 per 1,000 persons/yr. Age-adjusted annual ADHF incidence was highest for black men
(15.7 per 1,000), followed by black women (13.3 per 1,000), white men (12.3 per 1,000), and
white women (9.9 per 1,000). Of incident ADHF events with heart function assessment (89%),
53% had reduced the ejection fraction (heart failure with reduced ejection fraction [HFrEF]) and
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47% had preserved ejection fraction (heart failure with preserved ejection fraction [HFpEF]).
Black men had the highest proportion of acute HFrEF events (70%); white women had the highest
proportion of acute HFpEF (59%). Age-adjusted 28-day and 1-year case fatality after an incident
ADHF was 10.4% and 29.5%, respectively. Survival did not differ by race or gender. In
conclusion, ADHF hospitalization and HF type varied by both race and gender, but case fatality
rates did not. Further studies are needed to explain why black men are at higher risk of
hospitalized ADHF and HFrEF.
Estimates of incident heart failure (HF) rates1 are often based on hospital discharge
diagnoses codes that include chronic HF cases and possibly non-HF cases and, thus, may not
reflect the actual number of hospitalizations for acute decompensated heart failure (ADHF).
Because most HF patients are likely to be hospitalized within 5 years, 17% because of acute
decompensation,2 reliable estimates are needed to better understand and track the risk,
burden, and outcomes of HF. To assess the impact of clinical management on survival of
HF, and the effect of risk factors and their control on HF incidence, it is important to obtain
community-based estimates of ADHF events and monitor their changes. Previous studies
reported that approximately half of overt HF cases are heart failure with preserved ejection
fraction (HFpEF),3,4 but it is unclear if this distribution exists in diverse communities or in
similar proportions across race-gender groups. The Atherosclerosis Risk in Communities
(ARIC) study monitors prevalence and incidence of hospitalized ADHF in 4 communities.
We describe here our first 5-year estimates of validated hospitalized acute decompensated
HF events and case fatality (CF) by race, gender, and HF types.
Methods
The 4 ARIC study communities include Forsyth County, North Carolina; Jackson,
Mississippi; Minneapolis, Minnesota; and Washington County, Maryland. Average gender-
and race-specific population estimates for each study community were computed for 2005 to
2009 by extrapolations from the 2000 and 2010 US censuses. The estimated population size
aged ≥55 years were Forsyth County, 395,782 (20.8% black); Jackson, 171,241 (60.9%
black); Minneapolis suburbs, 253,225; and Washington County, 174,414. Because the
Minneapolis suburbs and Washington County were predominately white, blacks from these
2 communities were not included in the final analysis.
Community surveillance of hospitalized ADHF began on January 1, 2005. Methods of event
ascertainment and classification have been described previously.5 Briefly, a stratified
random sample of eligible hospitalizations in 2005 to 2009 for HF was selected based on 3
criteria: (1) International Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) discharge diagnosis codes for HF or HF-related condition (398.91, 402.01,
402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 415.0, 416.9, 425.4, 428.x,
518.4, and 786.0x) in any position; (2) age ≥55 years at the time of hospital discharge; and
(3) home address within boundaries of the ARIC communities. The sampling varied by
ICD-9-CM discharge codes (428 and non-428), field center, gender, and race (by race in
Forsyth County and Jackson only) to achieve similar SEs across these groups (https://
www2.cscc.unc.edu/aric/surveillance-manuals).
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Eligible hospitalizations (unweighted n = 10,500) were abstracted by trained abstractors if
the medical record documented any evidence of decompensation or new onset of HF
symptoms or any mention by a physician that HF was the reason for hospitalization. Fully
abstracted cases (unweighted n = 6,399) were independently classified by computer
algorithm or 2 physicians of the ARIC Mortality and Morbidity Classification Committee
into 1 of 5 categories as previously described5: definite ADHF, possible ADHF, chronic
stable HF, HF unlikely, or unclassifiable. Disagreements were adjudicated by the chair of
the Mortality and Morbidity Classification Committee (HF specialist). Definite or possible
ADHF required evidence from symptoms, signs, imaging, or treatment of an acute
exacerbation, worsening or new onset of symptoms, or other decompensated circulatory
state. For the purpose of this report, hospitalized HF classification was categorized as:
ADHF (definite or possible ADHF), chronic HF, and no HF (HF unlikely or unclassifiable).
ADHF events were further classified as heart failure with reduced ejection fraction (HFrEF;
current or most recent left ventricular ejection fraction [LVEF] <50%), HFpEF (LVEF
≥50% or greater), or unclassifiable (unknown LVEF).
An incident ADHF event was defined as a hospitalization for ADHF with no previous
hospitalization for HF noted in the medical record. Recurrent ADHF was defined as a
hospitalized ADHF event with a previous hospitalization for HF. Vital status of hospitalized
HF events within 1 year after discharge was determined by linkage with the National Death
Index.
Population-based estimates for each community were computed by age, gender, and race on
the basis of intercensal estimates derived by extrapolation from US Census data. After
excluding a small number of nonblack minorities (n = 149), few blacks in 2 predominately
white communities (Minnesota and Washington County; n = 81), and 1 with missing
sampling information, the final sample included 6,168 hospitalizations with HF screening
ICD-9-CM codes for the year 2005 to 2009. The weighted sample corresponded to 42,413
hospitalizations.
To account for the sampling design, all analyses were weighted by the inverse of the
sampling probability. Age-specific rates and their SEs were calculated by Poisson
regression. Rates were adjusted for age by direct standardization to the US population in
2000 and are reported as an average per year over the 5 years. Age-adjusted mortality curves
were created based on Cox models with age as a covariate. The 28-day and 1-year CF
percentages were computed by gender and race. All CF percentages were adjusted for age
by the direct method using the ARIC combined hospitalized HF events as the standard;
gender-specific percentages were also adjusted for race. Additional multivariable-adjusted
regression analyses for CF included prevalent coronary heart disease, hypertension, diabetes,
body mass index, asthma, or chronic obstructive pulmonary disease as covariates.
Results
Of the 42,413 HF-eligible hospitalizations, 41.2% were validated as ADHF, 9.0% as chronic
HF, and 49.8% were classified as no HF; the most common ICD-9-CM discharge code was
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428.xx (congestive HF, 89.1%). Of the validated hospitalized HF events, 82% were ADHF;
76.7% had either previous outpatient diagnosis of HF (73.4%) or treatment for HF (64.9%).
Of hospitalized ADHF events, 63.6% were incident hospitalized ADHF (53.2% of which
had previous HF diagnosis) and 36.4% were recurrent events. Although 92.0% of those with
ICD-9-CM code 428 listed as the primary diagnosis were validated ADHF, 42.3% of all
ADHF events (37.3% of incident ADHF) had ICD-9-CM code 428 as the first listed
diagnosis. Demographic and clinical characteristics were similar between all hospitalized
ADHF events and the subset with incident hospitalized ADHF (Table 1). Assessment of
heart function either before or during the hospitalization was available in most patients. The
most common co-morbidities were hypertension, coronary disease, chronic kidney disease
(defined as stage 3 or worse), and diabetes. Of incident ADHF events, 12.3% were preceded
by an acute myocardial infarction or unstable angina. Other possible precipitating factors of
incident ADHF, in decreasing order, included atrial fibrillation or atrial flutter (10.7% of
cases with a precipitating factor identified), pneumonia (9.4%), noncompliance with
medications (9.4%), other infection (9.2%), noncompliance with diet (4.9%), excess fluid
intake or administration (3.3%), and stroke or transient ischemic attack (1.2%).
The incidence of hospitalized ADHF was 11.6 per 1,000 persons, aged ≥55 years, per year,
and the rate of recurrent hospitalized ADHF was 6.6 per 1,000 persons per year. Incidence
increased with advancing age in the overall population and in each race-gender group (p
<0.001; Table 2). The incidence was higher in men than women overall (age-adjusted p
<0.001) and for each age group (all p <0.001). The rate in blacks was significantly higher
than the rates in whites, overall and for all age groups except those ≥75 years (p ≤0.005).
The age-adjusted incidence of hospitalized ADHF was highest in black men, followed by
black women, white men, and white women. Age-adjusted recurrence rates of hospitalized
ADHF and age-adjusted hospitalization rates of ADHF showed similar patterns (Figure 1).
Rates did not differ significantly by community. When the definition of incident events
excluded those with a previous diagnosis of HF (56%), the incidence estimates were lower,
as expected, but the race-gender patterns were unchanged except that differences in rates
between all men and all women and between men and women ≥75 years were no longer
statistically significant (Supplementary Table 1).
Among incident ADHF cases, mean LVEF was 42.4% (SE 0.4%; i.e., mean of the lowest
LVEF estimates available), with 53.0% having HFrEF and 47.0% having HFpEF (Table 1).
For most incident ADHF cases, the etiology of HF was not specifically identified in the
chart; however, 15.4% were ischemic cardiomyopathy, 7.1% systolic HF/other
cardiomyopathy, 5.5% idiopathic dilated cardiomyopathy, 2.3% hypertensive
cardiomyopathy, 2.3% diastolic HF, 1.0% cor pulmonale, and 0.2% hypertrophic
cardiomyopathy. The overall age-adjusted incidence was higher for ADHF from HFrEF
(8.31, 95% confidence interval [CI] 7.35 to 9.28 per 1,000 persons, aged ≥55 years, per
year) than for ADHF from HFpEF (6.22, 95% CI 5.38 to 7.06 per 1,000 persons, aged ≥55
years, per year).
Black men had the highest proportion of incident acute decompensated HFrEF events
followed by white men, black women, and white women (p <0.001; Table 3). White women
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had the highest proportion of incident acute HFpEF events followed by black women, white
men, and black men (p <0.001). However, black women had similar or slightly higher
proportion of incident HFrEF compared with HFpEF (p = 0.22). All validated ADHF events
showed similar patterns although black women had more acute HFrEF (p = 0.002).
The age-adjusted CF after an incident hospitalized ADHF was 10.4% (95% CI 8.5 to 12.2)
at 28 days and 29.5% (95% CI 26.9 to 32.0) at 1 year. Although the ageadjusted mortality
curve over 1 year appears to be higher in white men (Figure 2), this difference was not
statistically significant at either 28 days or at 365 days. Figure 3 shows the age-adjusted 28-
day and 1-year CF by ADHF type, gender, and race-gender groups. CF at 28 days and 1 year
was higher after an incident HFrEF event than after an incident HFpEF for most race-gender
groups, except for white women who have more HFpEF. There were no differences between
race-gender groups. When age-adjusted CF was additionally adjusted for prevalent coronary
heart disease, hypertension, diabetes, body mass index, asthma, or chronic obstructive
pulmonary disease, CF estimates were modestly decreased, but there were still no
differences between race-gender groups. When recurrent (prevalent) acute HF cases were
included, the mortality curves and trends of CF were similar, except the multivariable-
adjusted 1-year CF was higher in all men with HFrEF (33%, 95% CI 29 to 38) than in all
women with HFrEF (25%, 95% CI 20 to 30, p = 0.009). When the definition of incident
events excluded those with a previous diagnosis of HF, 1-year CF estimates were lower by
approximately 5%, but the race-gender patterns were unchanged.
Discussion
We found that ADHF hospitalization rates and HF type varied by race and gender, whereas
CF did not. The ARIC study is unique because it differentiates ADHF from chronic stable
HF, contributing more specificity than older classification criteria (e.g., Framingham) and
ICD-9-CM codes.5 In addition, the ARIC communities are relatively racially diverse
allowing for evaluation of event rates among whites and blacks. Black men had the highest
incidence and recurrence rates of hospitalized ADHF, whereas white women had the lowest
rates. These findings suggest that black men have more severe HF or less control of their
HF, or both, that lead to more frequent hospitalizations.
Also novel is our study demonstrates that there is a disparity in incidence of ADHF by both
race and gender. Previous population-based studies of incident HF events6-18 demonstrated
various methodologic weaknesses, notably, populations of predominantly white participants
and inclusion of chronic HF. For example, most studies allowed chronic therapy for HF as
sufficient for their definition.11,12 The only known large community-based studies to
specifically examine rates of hospitalized ADHF did so in mostly white populations (in
Worcester, Massachusetts, and Minneapolis-St. Paul, Minnesota).16,19 Compared with these
previous studies, the incidence of hospitalized ADHF in our population were two- to
fourfold higher, which probably reflects our more diverse population or inclusion of patients
with previous outpatient history of HF.
Compared with the few epidemiologic studies that included racially diverse populations
(Health ABC and MESA studies), our overall findings were similar in that blacks were
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found to have a relatively high incidence of HF.11,12,18 The recent study of Medicare
beneficiaries based solely on ICD-9-CM discharge codes described similar patterns, with
black men having the highest hospitalization rates for HF.20 In the Health ABC and MESA
cohorts, where blacks also had the highest incidence of HF,11,18 the distribution of HFrEF
and HFpEF based on limited LVEF data in these cohorts was similar to our community-
based study. Although other reports have suggested HFpEF accounts for half of the HF
burden,3,4,21-24 our results show that this proportion may differ by both race and gender,
where HFrEF is more frequent among black women, black men, and white men. The
explanations may be that blacks or men are more likely to have been hospitalized with
HFrEF than their counterparts with HFpEF, or there may be a combination of information
bias and selection bias, with HFrEF to be more likely classified as ADHF.
Although 92% of hospitalizations with primary ICD-9-CM discharge code of 428 were
validated ADHF events, only 42% of ADHF events (37% incident ADHF) had a primary
discharge code of 428; and more than half of the ADHF cases had another primary discharge
code. The high specificity and low sensitivity of a primary discharge ICD-9-CM code 428
found in this study suggest that HF events identified solely by ICD-9-CM codes may not
accurately estimate the rate of HF-related hospitalizations, similar to previous reports.5,9,17
Thus, the estimated national statistics of 1,102,000 hospitalizations for HF (803,000 for aged
65 years or older) in 2006, based on the National Hospital Discharge Survey6 or the HF
hospitalization rates of 1957 to 2845 per 100,000 person-years in Medicare Beneficiaries
(1998 to 2008),20 may be an underestimate of acute decompensated HF because these
surveys were based on ICD-9-CM codes alone.
There have been mixed results regarding survival after hospitalized HF. Estimates from
Olmsted County suggested that men have worse survival compared with women,15 whereas
the recent Medicare survey20 and the Organized Program to Initiate Lifesaving Treatment in
Hospitalized Patients with Heart Failure (OPTIMIZE-HF)24 and Get With The Guidelines-
Heart Failure (GWTG-HF)25 patient registries suggested that whites had worse survival
compared with blacks. A previous report from the ARIC cohort13 suggested that survival
after hospitalization for HF is worse in blacks compared with whites. Race and gender
differences may be related to the cause, LVEF,23,24 co-morbidities26 and their control,27
compliance, and socioeconomic factors including access to care and quality of care.28
However, the present findings from ARIC community surveillance add to the uncertainty of
whether CF differs by race or gender. One-year CF was 30% for each race-gender group;
this is higher than national estimates of 20% that are based on more homogenous
populations, namely the Framingham Heart Study and Olmsted County.1 The lack of race or
gender differences in short-term survival in the present study should be confirmed in other
diverse population-based studies.
Limitations of this study include, first, that our study population originates from 4 US
communities and is restricted to those ≥55 years old and, therefore, does not represent the
total US population. Second, our definition of incident hospitalized HF is based on the lack
of previous hospitalization for HF and includes patients with a previous diagnosis of HF
(56%). Our focus is on HF events that become serious enough to require hospitalization, and
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for these, we look for “first hospitalizations” as we have done for other cardiovascular
diseases.29 When our definition of incident events excluded those with a previous diagnosis
of HF, incidence estimates were lower, as expected, but the trends and inferences were
unchanged. Potential precipitating factors were identified by explicit documentation of such
in the clinical record, which may be speculative, incomplete, and potentially inaccurate;
however, previous reports using similar methods have identified similar precipitants.30
Finally, the present study was limited to hospitalized HF and did not include outpatient HF
events. Nevertheless, the ARIC study is the first to differentiate hospitalization rates of
ADHF from chronic HF in a biracial community-based population and confirms that HF
hospitalization identified solely by ICD-9 codes may not accurately estimate the burden of
ADHF.
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Age-adjusted rates of first, recurrent, and all hospitalized ADHF events: 2005 to 2009
Atherosclerosis Risk in Communities Heart Failure Community Surveillance. Rates are
adjusted for age by the direct method, according to the distribution of the US population in
2000. *p Value <0.05 for the gender-specific comparison between black and white groups.
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Age-adjusted 1-year mortality curves for incident hospitalized ADHF cases: 2005 to 2009
Atherosclerosis Risk in Communities Heart Failure Community Surveillance.
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Age-adjusted (A) 28-day and (B) 365-day CF percentages and 95% CI for incident
hospitalized ADHF cases: 2005 to 2009 Atherosclerosis Risk in Communities Heart Failure
Community Surveillance. All percentages are adjusted for age by direct method using the
ARIC combined hospitalized HF events as the standard. Gender-specific CF percentages are
also adjusted for race. Minor discrepancies with the mortality curve (Figure 2) are because
of differences in age-adjustment methods.
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Table 1
Characteristics of the validated hospitalized ADHF cases: 2005 to 2009 Atherosclerosis Risk in Communities
Study Heart Failure Community Surveillance
Variable All ADHF (n = 3,695) Incident ADHF (n = 2,252)
Mean or % 95% CI Mean or % 95% CI
Age (yrs) 75.6 75.2–75.9 75.9 75.5–76.4
Women 53.6% 52.2–55.1 55.3% 53.3–57.3
Caucasian 72.4% 71.2–73.5 78.5% 77.0–80.0
Black men 15.2% 14.3–16.2 12.2% 11.0–13.4
Black women 12.4% 11.7–13.2 9.3% 8.4–10.3
White men 38.4% 37.0–39.9 43.1% 41.1–45.2
White women 33.9% 32.6–35.3 35.4% 33.5–37.4
Heart function assessed*,† 90.1% 88.9–91.2 88.8% 87.1–90.2
LVEF before hospitalization (%)*,† 40.7 39.9–41.6 44.2 43.1–45.4
LVEF during hospitalization (%)* 41.9 41.1–42.7 43.4 42.5–44.3
HFrEF 58.3% 56.4–60.2 53.0% 50.5–55.5
Previous diagnosis of HF 70.1% 68.4–71.8 53.2% 50.8–55.6
Body mass index (kg/m2)* 29.0 28.6–29.4 29.2 28.8–29.7
Obesity* 26.0% 24.4–27.6 27.4% 25.4–29.6
Current smoker 14.2% 13.0–15.5 14.8% 13.2–16.6
Hypertension 83.7% 82.2–85.1 83.2% 81.2–85.0
Coronary heart disease 67.5% 65.8–69.1 63.1% 60.8–65.3
Acute MI or unstable angina pectoris 10.7% 9.6–12.0 11.7% 10.3–13.4
Atrial fibrillation or flutter 35.8% 34.1–37.6 31.9% 29.7–34.2
Valvular heart disease 23.6% 22.1–25.2 21.2% 19.3–23.2
Diabetes mellitus 46.6% 44.8–48.4 42.7% 40.3–45.1
Stroke or transient ischemic attack 20.0% 18.5–21.5 20.4% 18.5–22.5
Peripheral vascular disease 13.9% 12.7–15.2 13.2% 11.7–14.9
Asthma or chronic obstructive pulmonary disease 37.7% 35.9–39.5 36.0% 33.8–38.4
Sleep apnea 9.1% 8.1–10.2 8.6% 7.4–10.1
Chronic kidney disease‡ 66.1% 64.3–67.8 63.8% 61.5–66.0
The numbers and percentages listed in the table are weighted to account for sampling probabilities (6,168 unweighted sampled events resulting in
3,695 hospitalized ADHF events and 2,252 incident hospitalized ADHF events). Data were available for 100% of each characteristic except for
those noted by “*.” The co-morbidities included in this table (such as hypertension and coronary heart disease) were historical diagnoses recorded
in the medical record. History of previous HF diagnosis and co-morbidities were obtained from the current hospitalization. Imaging reports of
LVEF within 2 years of the current hospitalization were abstracted. Obesity was defined as body mass index ≥30 kg/m2.
MI = myocardial infarction.
*
The percentage of all hospitalized ADHF and all incident ADHF, respectively, with available data for each of the following characteristics: heart
function assessed: 90.1%, 88.8%; LVEF before hospitalization: 54.3%, 44.2%; LVEF during hospitalization: 59.9%, 64.9%; and body mass index
and obesity: 73.1%, 74.0%.
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†
Assessment of heart function (ventricular systolic and diastolic function) was documented in the medical records (historical reference) or in
reports of cardiac imaging (echocardiography, cardiac catheterization, and nuclear or other cardiac imaging tests). If there was more than 1
assessment of LVEF, the lowest value was used.
‡
Chronic kidney disease was defined as history of dialysis dependence and/or estimated glomerular filtration rate (using the Modification of Diet in
Renal Disease method) of <60 ml/min/1.73 m2.
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